| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
9 companies
Healy James is a Director at RAPP, with reported holdings spanning 9 companies. Recent filings cover 32 purchases and 10 sales. Those positions are worth an estimated $111.7M at current prices.
Our model assigns Healy James a below-average insider score of 44/100, based on 10 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -22.1%.
Healy James's largest disclosed position is in RAPP as Director, worth about $60.4M. Net of sales, the recent Form 4 record there shows accumulation of 1,572,336 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 969,480 | $21.00 | $20,359,080.00 | +50.9% | - | - | |
| Sep 27, 2024 | BIOA Bioage Labs, Inc. | Director | Buy | 666,665 | $18.00 | $11,999,970.00 | -104.1% | -72.0% | -74.2% | |
| Jul 1, 2024 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 44,032 | $24.52 | $1,079,575.36 | -1,384% | -19.5% | -55.5% | |
| Jun 10, 2024 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 558,824 | $17.00 | $9,500,008.00 | -104.8% | -24.9% | -49.8% | |
| Jan 30, 2024 | AVBP Arrivent Biopharma, Inc. | Director | Buy | 444,444 | $18.00 | $7,999,992.00 | +35.5% | -25.7% | +31.9% | |
| Dec 13, 2023 | NTRA Natera, Inc. | Director | Sell | 644,000 | $58.75 | $37,835,000.00 | -100% | +51.1% | +177.0% | |
| Nov 16, 2022 | NTRA Natera, Inc. | Director | Sell | 2,400 | $37.71 | $90,498.00 | -100% | +14.5% | +43.8% | |
| Sep 29, 2021 | CHRS Coherus Oncology, Inc. | Director | Sell | 434,555 | $16.68 | $7,250,063.05 | -100% | +5.2% | -43.2% | |
| Jul 22, 2021 | NTRA Natera, Inc. | Director | Buy | 2,400 | $113.00 | $271,200.00 | New | -3.8% | -61.7% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director | Buy | 450,000 | $20.00 | $9,000,000.00 | +19.5% | - | - |